Modulatory effects ofBifidobacterium longumBB536 on defecation in elderly patients receiving enteral feeding
Authors:
- Jin-Zhong XiaoJXJin-Zhong Xiao
- Akira ShirahataASAkira Shirahata
- Mieko BabaMBMieko Baba
- Akie AbeAAAkie Abe
- Koichi OgawaKOKoichi Ogawa
- Taeko ShimodaTSTaeko Shimoda
Open Access
- 1 January 2013
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 19 (14) , 2162-70
Abstract
To investigate the effects of the probiotic Bifidobacterium longum BB536 on the health management of elderly patients receiving enteral feeding. Two double-blind, placebo-controlled trials were performed with long-term inpatients receiving enteral tube feeding at Kitakyushu Hospital Group, Fukuoka, Japan. BB536 was administered as BB536-L and BB536-H powders that contained approximately 2.5 × 10¹⁰ and 5 × 10¹⁰ cfu of BB536, respectively. In the first trial, 83 patients (age range: 67-101 years) were randomized into 2 groups that received placebo (placebo group) or BB536-H (BB536 group) powders. In the second trial, 123 patients (age range: 65-102 years) were randomized into 3 groups, and each group received placebo (placebo group), BB536-L (BB536-L group), or BB536-H (BB536-H group) powders. Each patient received the study medication for 16 wk after 1 wk of pre-observation. Fecal samples were collected from each patient prior to and after the intervention during Trial 2. Clinical observations included body temperature, occurrence of infection, frequency of defecation, and fecal microbiota. No significant changes were observed in the frequency of defecation for either treatment in Trial 1. However, a significant change was noted in the BB536-L group (P = 0.0439) in Trial 2 but not in the placebo or BB536-H groups. Subgroup analyses based on the frequency of defecation for each patient during the pre-observation period for both trials revealed significant increases in bowel movements in patients with a low frequency of defecation and significant decreases in the bowel movements of patients with a high frequency of defecation during the intervention period in the BB536 groups. The combination of Trials 1 and 2 data revealed a modulatory effect of BB536 ingestion on the changes in bowel movements. Significantly increased bowel movements were observed in patients in the low frequency subgroup with significant intergroup differences (P < 0.01). Significantly decreased bowel movements were observed in patients in the high subgroup, but no significant intergroup differences were observed compared with the placebo group. BB536 ingestion increased the prevalence of normally formed stools. BB536 intake also significantly (P < 0.01) increased the cell numbers of bifidobacteria in fecal microbiota, and significant intergroup differences were observed at week 16. No adverse events were reported in any group. Our results suggest that BB536 ingestion modulated the intestinal environment and may have improved the health care of elderly patients receiving enteral feeding.Keywords
This publication has 25 references indexed in Scilit:
- Clinical Effects of Probiotic Bifidobacterium longum BB536 on Immune Function and Intestinal Microbiota in Elderly Patients Receiving Enteral Tube FeedingJournal of Parenteral and Enteral Nutrition, 2012
- Laxatives as a Risk Factor for Iatrogenic Falls in Elderly SubjectsDrugs & Aging, 2010
- [National study on acceptance by Japanese nursing homes of patients with feeding tubes].Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 2010
- A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patientsWorld Journal of Gastroenterology, 2010
- Differences in Fecal Microbiota in Different European Study Populations in Relation to Age, Gender, and Country: a Cross-Sectional StudyApplied and Environmental Microbiology, 2006
- Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profilesGut, 2001
- YOGHURT WITH BIFIDOBACTERIUM LONGUM REDUCES ERYTHROMYCIN-INDUCED GASTROINTESTINAL EFFECTSThe Lancet, 1987
- Complications Occurring during Enteral Nutrition Support: A Prospective StudyJournal of Parenteral and Enteral Nutrition, 1983
- [Investigation of the stool frequency in elderly who are bed ridden and its improvements by ingesting bifidus yogurt].1982
- Ecology of the bifidobacteriaThe American Journal of Clinical Nutrition, 1977